Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 3 studies | 29% ± 13% |
Insufficient scRNA-seq data for expression of DMRTA2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 55% | 23.06 | 1466 / 2642 | 42% | 7.48 | 298 / 705 |
esophagus | 39% | 76.60 | 561 / 1445 | 53% | 5.55 | 97 / 183 |
tonsil | 0% | 0 | 0 / 0 | 73% | 12.10 | 33 / 45 |
uterus | 1% | 0.20 | 2 / 170 | 56% | 6.40 | 257 / 459 |
lung | 4% | 1.38 | 22 / 578 | 47% | 4.20 | 540 / 1155 |
bladder | 0% | 0 | 0 / 21 | 41% | 3.31 | 207 / 504 |
intestine | 1% | 0.18 | 11 / 966 | 29% | 1.57 | 153 / 527 |
stomach | 1% | 0.23 | 2 / 359 | 18% | 0.93 | 51 / 286 |
pancreas | 0% | 0 | 0 / 328 | 7% | 0.32 | 12 / 178 |
skin | 0% | 0.11 | 6 / 1809 | 6% | 0.45 | 29 / 472 |
ovary | 0% | 0 | 0 / 180 | 5% | 0.14 | 23 / 430 |
breast | 1% | 0.18 | 4 / 459 | 4% | 0.19 | 50 / 1118 |
prostate | 4% | 0.68 | 10 / 245 | 0% | 0.00 | 1 / 502 |
adrenal gland | 1% | 0.40 | 3 / 258 | 3% | 0.09 | 7 / 230 |
thymus | 2% | 0.44 | 14 / 653 | 0% | 0.14 | 3 / 605 |
blood vessel | 1% | 0.33 | 20 / 1335 | 0% | 0 | 0 / 0 |
liver | 0% | 0.06 | 1 / 226 | 1% | 0.02 | 4 / 406 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.02 | 6 / 901 |
peripheral blood | 1% | 0.33 | 6 / 929 | 0% | 0 | 0 / 0 |
adipose | 0% | 0.10 | 5 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.04 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002052 | Biological process | positive regulation of neuroblast proliferation |
GO_0048665 | Biological process | neuron fate specification |
GO_0035914 | Biological process | skeletal muscle cell differentiation |
GO_0007405 | Biological process | neuroblast proliferation |
GO_0007281 | Biological process | germ cell development |
GO_0021796 | Biological process | cerebral cortex regionalization |
GO_0007548 | Biological process | sex differentiation |
GO_0071542 | Biological process | dopaminergic neuron differentiation |
GO_0048866 | Biological process | stem cell fate specification |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | DMRTA2 |
Protein name | Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5) |
Synonyms | DMRT5 |
Description | FUNCTION: May be involved in sexual development. FUNCTION: May be involved in sexual development. . FUNCTION: May be involved in sexual development. . |
Accessions | B7ZLH1 ENST00000418121.5 Q96SC8 B9EG80 ENST00000404795.4 |